Prism Medico & Pharmacy (BOM:512217) Notes Receivable: ₹0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512217 Prism Medico & Pharmacy Ltd BOM:512217
53 GF Score
Price ₹27.74
GF Value ₹27.77
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Prism Medico & Pharmacy Notes Receivable?

Prism Medico & Pharmacy BOM:512217 -5.39% 53 Notes Receivable is ₹0.00 Mil as of Mar. 2026. GuruFocus rates BOM:512217 with a GF Score™ of 53/100 and a GF Value™ of ₹27.77 (Fairly Valued). The stock has 4 warning signs investors should review.

Prism Medico & Pharmacy's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0.00 Mil.

Prism Medico & Pharmacy Notes Receivable Related Terms

Prism Medico & Pharmacy Notes Receivable Historical Data

* Premium members only.

The historical data trend for Prism Medico & Pharmacy's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prism Medico & Pharmacy Notes Receivable Chart

Prism Medico & Pharmacy Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Prism Medico & Pharmacy Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:512217
53GF Score
Prism Medico & Pharmacy Ltd BOM:512217
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prism Medico & Pharmacy Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.00 Mil mean?
Prism Medico & Pharmacy (BOM:512217) has a Notes Receivable of ₹0.00 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Prism Medico & Pharmacy and its competitors.
Is Prism Medico & Pharmacy's Notes Receivable too high?
Prism Medico & Pharmacy's current Notes Receivable is ₹0.00 Mil. Overall, Prism Medico & Pharmacy has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Prism Medico & Pharmacy's Notes Receivable compare to ADM and BG?
Prism Medico & Pharmacy's Notes Receivable of ₹0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Consumer Packaged Goods company?
A good Notes Receivable depends on the Consumer Packaged Goods industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Prism Medico & Pharmacy and its competitors. Prism Medico & Pharmacy's current Notes Receivable is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Medico & Pharmacy stock overvalued right now?
Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Fairly Valued. The stock's GF Value™ is ₹27.77, compared to a current price of ₹27.74 — trading 0.1% below its estimated fair value. The current Notes Receivable is ₹0.00 Mil. Prism Medico & Pharmacy's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current Notes Receivable is ₹0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?

Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be undervalued. The current stock price of ₹27.74 is trading 0.1% below its estimated GF Value™ of ₹27.77. GuruFocus considers Prism Medico & Pharmacy to be Fairly Valued.

Key valuation signals for BOM:512217:

  • Notes Receivable: ₹0.00 Mil
  • GF Value™: ₹27.77 vs. price of ₹27.74 (0.1% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prism Medico & Pharmacy Business Description

Address C/o. Sunrise Enterprises, Suketi Road, Sirmaur District, Kala Amb, HP, IND, 173030
Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.
53GF Score

Get the complete analysis for BOM:512217

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹27.74
Price
₹27.77
GF Value